CMS Likely Will Not Restrict Coverage For Drug-Coated Stents

CMS likely will not restrict Medicare coverage for drug-coated stents in response to recent concerns that they can increase risk for blood clots, according to Marcel Salive, director of medical and surgical services at the agency’s coverage and analysis group, the Wall Street Journal reports. [click link for full article]

More: continued here

Filed under: Medical Devices on October 25th, 2007